These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 33480877)

  • 1. Convalescent Plasma: Education and Administration Implications.
    Martin JC
    Clin J Oncol Nurs; 2021 Feb; 25(1):28-32. PubMed ID: 33480877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Convalescent Plasma for the Treatment of COVID-19: Perspectives of the National Institutes of Health COVID-19 Treatment Guidelines Panel.
    Pau AK; Aberg J; Baker J; Belperio PS; Coopersmith C; Crew P; Grund B; Gulick RM; Harrison C; Kim A; Lane HC; Masur H; Sheikh V; Singh K; Yazdany J; Tebas P;
    Ann Intern Med; 2021 Jan; 174(1):93-95. PubMed ID: 32976026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Convalescent Whole Blood Donors Screening Strategies for Providing Efficient and Safe COVID-19 Survivors' Plasma and Other Blood Components.
    Mandel M; Gurevich M; Mandelboim M; Amital H; Achiron A
    Isr Med Assoc J; 2021 Jan; 23(1):7-10. PubMed ID: 33443334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study.
    Abolghasemi H; Eshghi P; Cheraghali AM; Imani Fooladi AA; Bolouki Moghaddam F; Imanizadeh S; Moeini Maleki M; Ranjkesh M; Rezapour M; Bahramifar A; Einollahi B; Hosseini MJ; Jafari NJ; Nikpouraghdam M; Sadri N; Tazik M; Sali S; Okati S; Askari E; Tabarsi P; Aslani J; Sharifipour E; Jarahzadeh MH; Khodakarim N; Salesi M; Jafari R; Shahverdi S
    Transfus Apher Sci; 2020 Oct; 59(5):102875. PubMed ID: 32694043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Convalescent Covid-19 plasma: Back-to-basics and ethics, and next steps.
    Garraud O; Burnouf T
    Transfus Clin Biol; 2021 Aug; 28(3):225-227. PubMed ID: 34362557
    [No Abstract]   [Full Text] [Related]  

  • 6. Case Report: Convalescent Plasma, a Targeted Therapy for Patients with CVID and Severe COVID-19.
    Van Damme KFA; Tavernier S; Van Roy N; De Leeuw E; Declercq J; Bosteels C; Maes B; De Bruyne M; Bogaert D; Bosteels V; Hoste L; Naesens L; Maes P; Grifoni A; Weiskopf D; Sette A; Depuydt P; Van Braeckel E; Haerynck F; Lambrecht BN
    Front Immunol; 2020; 11():596761. PubMed ID: 33329586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Convalescent Plasma for Pregnant Women with COVID-19: A Systematic Literature Review.
    Franchini M; Prefumo F; Grisolia G; Bergamini V; Glingani C; Pisello M; Presti F; Zaffanello M
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34206468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 convalescent plasma: phase 2.
    Knudson CM; Jackson JB
    Transfusion; 2020 Jun; 60(6):1332-1333. PubMed ID: 32374890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on newer approaches to prevent or treat COVID-19 infection: What we all need the most right now!!
    Seghatchian J; Acker JP; Putter JS
    Transfus Apher Sci; 2020 Oct; 59(5):102933. PubMed ID: 32919879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Convalescent plasma to treat coronavirus disease 2019 (COVID-19): considerations for clinical trial design.
    Barone P; DeSimone RA
    Transfusion; 2020 Jun; 60(6):1123-1127. PubMed ID: 32374891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Administration of Convalescent Plasma Improves Survival in Patients with Hematological Malignancies and COVID-19.
    Biernat MM; Kolasińska A; Kwiatkowski J; Urbaniak-Kujda D; Biernat P; Janocha-Litwin J; Szymczyk-Nużka M; Bursy D; Kalicińska E; Simon K; Mazur G; Wróbel T
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33800528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of convalescent plasma for the treatment of severe influenza.
    Xu Z; Zhou J; Huang Y; Liu X; Xu Y; Chen S; Liu D; Lin Z; Liu X; Li Y
    Crit Care; 2020 Jul; 24(1):469. PubMed ID: 32727526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Convalescent plasma regulation: A message in a bottle to the societies and regulatory authorities outside the US.
    Focosi D; Franchini M
    Transfus Apher Sci; 2023 Aug; 62(4):103715. PubMed ID: 37121870
    [No Abstract]   [Full Text] [Related]  

  • 14. Passive immunotherapies for COVID-19: The subtle line between standard and hyperimmune immunoglobulins is getting invisible.
    Focosi D; Franchini M
    Rev Med Virol; 2022 Jul; 32(4):e2341. PubMed ID: 35275607
    [No Abstract]   [Full Text] [Related]  

  • 15. Lessons From COVID-19: Raising the Stakes for Learning on the Job.
    Baker M
    Prof Case Manag; 2021 Mar-Apr 01; 26(2):111-112. PubMed ID: 33507022
    [No Abstract]   [Full Text] [Related]  

  • 16. Sustained prothrombotic changes in convalescent patients with COVID-19.
    von Meijenfeldt FA; Thålin C; Lisman T
    Lancet Haematol; 2021 Jul; 8(7):e475. PubMed ID: 34171275
    [No Abstract]   [Full Text] [Related]  

  • 17. Dark present, but look to the future.
    Ralph Edwards I; Lindquist M
    Int J Risk Saf Med; 2020; 31(2):43-44. PubMed ID: 32364136
    [No Abstract]   [Full Text] [Related]  

  • 18. Articles That May Change Your Practice: Current Evidence for Coronavirus Disease 2019 Therapies.
    MacDonald RD
    Air Med J; 2021; 40(3):153-156. PubMed ID: 33933216
    [No Abstract]   [Full Text] [Related]  

  • 19. Convalescent Plasma for Infectious Diseases: Historical Framework and Use in COVID-19.
    Ripoll JG; van Helmond N; Senefeld JW; Wiggins CC; Klassen SA; Baker SE; Larson KF; Murphy BM; Andersen KJ; Ford SK; Casadevall A; Joyner MJ
    Clin Microbiol Newsl; 2021 Feb; 43(4):23-32. PubMed ID: 33564204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Reply - Safety of Convalescent Plasma Transfusion.
    Juskewitch JE; Stubbs JR; Gandhi MJ
    Mayo Clin Proc; 2021 May; 96(5):1369. PubMed ID: 33958069
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.